Pikkelysömör: vizsgálatok itt: Kanada

In Kanada 19 Also abroad 274

19 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

2. fázisTaking people
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
Where
Saskatoon, Sherbrooke, Trois-Rivières
Életkor
18 év and over
People
300 worldwide
Run by
AbbVie
See details and how to joinNCT06865105
2. fázisNot yet taking people in Kanada
A Study to Assess the Safety and Effectiveness of COL-5671-PRO Capsules in Adults With Moderate-to-Severe Plaque Psoriasis
Where
Markham, Mississauga, Peterborough, Québec, Richmond Hill, Saskatoon
Életkor
18 év to 70 év
People
100
Run by
Coultreon Biopharma
See details and how to joinNCT07914231 · EU 2026-527405-38-00
No phaseTaking people
Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
Where
Montreal
Életkor
18 év and over
People
500
Run by
Innovaderm Research Inc.
See details and how to joinNCT05994976
3. fázisTaking people
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Where
Ajax, Barrie, Calgary, Edmonton, Hamilton, Kelowna, London, Markham, Mississauga, Montreal, Nanaimo, Newmarket, North Bay, Oakville, Ottawa, Peterborough, Québec, Richmond Hill, Sherbrooke, St. John's, Surrey, Toronto, Verdun, Winnipeg
Életkor
40 év and over
People
3040 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07116967 · EU 2023-503766-24-00
3. fázisTaking people
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Where
Edmonton, London, Montreal, Richmond Hill, St. John's, Toronto, Winnipeg
Életkor
12 év to 17 év
People
366 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06979453 · EU 2023-506296-97-00
3. fázisTaking people
A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis
Where
Calgary, Edmonton, Hamilton, Markham, Toronto
Életkor
4 év to 18 év
People
153 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT04772079 · EU 2022-502519-13-00
2. fázisTaking people
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Where
Ajax, Edmonton, Fredericton, London, Markham, Montreal, Peterborough, Québec, Surrey, Toronto, Waterloo
Életkor
18 év and over
People
240 worldwide
Run by
Oruka Therapeutics, Inc.
See details and how to joinNCT07449702 · EU 2026-526898-42-00
No phaseTaking people
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Where
Calgary, Halifax, Toronto, Winnipeg
Életkor
Up to 21 év
People
20 000 worldwide
Run by
Duke University
See details and how to joinNCT02418442
1. fázisTaking people
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Where
Toronto
Életkor
18 év and over
People
300 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT03816345
No phaseTaking people
Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Where
Ajax, Belleville, Calgary, Edmonton, Hamilton, London, Markham, Oakville, Ottawa, Peterborough, Saint-Jérôme, Thunder Bay, Toronto, Whitby, Winnipeg
Életkor
18 év and over
People
700 worldwide
Run by
AbbVie
See details and how to joinNCT07039110
No phaseTaking people
Modifying PEST for Psoriatic Arthritis Screening
Where
Barrie, Calgary, Edmonton, Fredericton, Greater Sudbury, Hamilton, Kelowna, London, Markham, Montreal, Ottawa, Québec, Richmond Hill, Saskatoon, Ste-Foy, Stoney Creek, Surrey, Toronto, Verdun, Waterloo, Winnipeg
Életkor
18 év and over
People
502
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06382051
1. fázisTaking people
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
Where
Calgary, Vancouver
Életkor
18 év and over
People
20 worldwide
Run by
UCB Biopharma SRL
See details and how to joinNCT06888193 · EU 2024-518689-29-00
No phaseTaking people
Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada
Where
Burlington, Hamilton, Kanata, Ottawa, Pickering, Saskatoon
Életkor
18 év and over
People
80
Run by
Chronicle Academy
See details and how to joinNCT07370766
3. fázisTaking people
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Where
Calgary, Toronto, Vancouver
Életkor
5 év to 17 év
People
40 worldwide
Run by
AbbVie
See details and how to joinNCT06100744 · EU 2023-506026-36-00
4. fázisTaking people
A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
Where
Ottawa, Québec
Életkor
18 év and over
People
100 worldwide
Run by
CARE ARTHRITIS LTD.
See details and how to joinNCT06454188 · EU 2023-510242-24-00
4. fázisTaking people
Multi-Center PAMPA Study
Where
St. John's, Toronto
Életkor
18 év and over
People
176 worldwide
Run by
NYU Langone Health
See details and how to joinNCT05004727
No phaseTaking people
Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis
Where
Toronto
Életkor
18 év and over
People
500
Run by
Charite University, Berlin, Germany
See details and how to joinNCT07298265
No phaseNot yet taking people in Kanada
Personalized Outreach for Equitable Treatment in Rheumatology
Where
Vancouver
Életkor
18 év and over
People
20
Run by
University of British Columbia
See details and how to joinNCT07022756
No phaseTaking people
Sex and Gender-based Analysis of the Effectiveness of Advanced Therapies in Psoriatic Arthritis
Where
Toronto
Életkor
18 év and over
People
540
Run by
Women's College Hospital
See details and how to joinNCT05954364